Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2,240 limb revascularizations
- PMID: 19476835
- DOI: 10.1016/j.jamcollsurg.2009.01.025
Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2,240 limb revascularizations
Abstract
Background: Outcomes after lower extremity revascularization are usually reported according to the level of peripheral arterial disease (PAD, aortoiliac or infrainguinal) or the method of treatment (open or endovascular surgery). Outcomes stratified by indication, ie, claudication or critical limb ischemia (rest pain and tissue loss), have not been well studied. The purpose of this study was to compare postoperative outcomes according to the preoperative indications.
Study design: Outcomes of 2,240 consecutive limb revascularizations in 1,732 patients from January 1998 through December 2005 were stratified and examined according to preoperative indication: claudication (n=999 limbs), ischemic rest pain (n=464 limbs), or tissue loss (n=777 limbs). End points measured included primary and secondary interventional or operative patency, limb salvage, survival, amputation-free survival, maintenance of ambulation, maintenance of independence, and resolution of presenting symptoms.
Results: The proportion of medical comorbidities and the severity of disease increased significantly by cohort from claudication to rest pain to tissue loss. With a mean followup of 1,089 days (range 0 to 3,689 days), overall outcomes performance declined consistently according to indication for all end points measured at 5 years (claudication, rest pain, tissue loss, p value): secondary reconstruction patency (93%, 80%, 66%, respectively; p < 0.001), limb salvage (99%, 81%, 68%, respectively; p < 0.001), survival (78%, 46%, 30%, respectively; p < 0.001), amputation-free survival (78%, 42%, 25%, respectively; p < 0.001), maintenance of ambulation (96%, 78%, 68%, respectively; p < 0.001), maintenance of independence (98%, 85%, 75%, respectively; p < 0.001), and resolution of presenting symptoms (79%, 61%, 42%, respectively; p < 0.001).
Conclusions: There is a declining spectrum of outcomes performance from claudication to rest pain to tissue loss. These findings question the accuracy of all previously published data for critical limb ischemia, for which rest pain and tissue loss are usually blended and reported as a single outcomes value.
Similar articles
-
One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.J Vasc Surg. 2006 Aug;44(2):296-302; discussion 302-3. doi: 10.1016/j.jvs.2006.04.045. Epub 2006 Jul 11. J Vasc Surg. 2006. PMID: 16814976
-
Postoperative outcomes according to preoperative medical and functional status after infrainguinal revascularization for critical limb ischemia in patients 80 years and older.Am Surg. 2005 Aug;71(8):640-5; discussion 645-6. Am Surg. 2005. PMID: 16217945
-
Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.J Vasc Surg. 2006 Oct;44(4):747-55; discussion 755-6. doi: 10.1016/j.jvs.2006.06.015. Epub 2006 Aug 22. J Vasc Surg. 2006. PMID: 16926083
-
Interventional management of critical limb ischemia in renal patients.Adv Chronic Kidney Dis. 2008 Oct;15(4):384-95. doi: 10.1053/j.ackd.2008.07.008. Adv Chronic Kidney Dis. 2008. PMID: 18805385 Review.
-
Infrainguinal bypass in end-stage renal disease: when is it justified?Semin Vasc Surg. 1997 Mar;10(1):42-8. Semin Vasc Surg. 1997. PMID: 9068076 Review.
Cited by
-
Muscle progenitor cells are required for skeletal muscle regeneration and prevention of adipogenesis after limb ischemia.Front Cardiovasc Med. 2023 Mar 2;10:1118738. doi: 10.3389/fcvm.2023.1118738. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36937923 Free PMC article.
-
Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet-Fed Mice.Diabetes. 2016 Sep;65(9):2553-68. doi: 10.2337/db16-0387. Epub 2016 Jun 9. Diabetes. 2016. PMID: 27284110 Free PMC article.
-
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.J Transl Med. 2011 Sep 27;9:165. doi: 10.1186/1479-5876-9-165. J Transl Med. 2011. PMID: 21951607 Free PMC article. Clinical Trial.
-
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia.Front Physiol. 2015 Nov 18;6:336. doi: 10.3389/fphys.2015.00336. eCollection 2015. Front Physiol. 2015. PMID: 26635622 Free PMC article. Review.
-
Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.J Mol Cell Cardiol. 2016 Aug;97:191-6. doi: 10.1016/j.yjmcc.2016.05.015. Epub 2016 Jun 1. J Mol Cell Cardiol. 2016. PMID: 27262673 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources